Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $157.92 million. The enterprise value is $115.32 million.
| Market Cap | 157.92M |
| Enterprise Value | 115.32M |
Important Dates
The last earnings date was Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 80.57 million shares outstanding. The number of shares has decreased by -2.19% in one year.
| Current Share Class | 80.57M |
| Shares Outstanding | 80.57M |
| Shares Change (YoY) | -2.19% |
| Shares Change (QoQ) | +4.45% |
| Owned by Insiders (%) | 9.73% |
| Owned by Institutions (%) | 21.79% |
| Float | 72.73M |
Valuation Ratios
The trailing PE ratio is 10.14.
| PE Ratio | 10.14 |
| Forward PE | n/a |
| PS Ratio | 2.07 |
| Forward PS | 2.60 |
| PB Ratio | 2.35 |
| P/TBV Ratio | 2.35 |
| P/FCF Ratio | 12.15 |
| P/OCF Ratio | 10.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.41, with an EV/FCF ratio of 8.87.
| EV / Earnings | 7.52 |
| EV / Sales | 1.51 |
| EV / EBITDA | 5.41 |
| EV / EBIT | 5.83 |
| EV / FCF | 8.87 |
Financial Position
The company has a current ratio of 3.15, with a Debt / Equity ratio of 0.13.
| Current Ratio | 3.15 |
| Quick Ratio | 1.97 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 0.65 |
| Interest Coverage | 14.36 |
Financial Efficiency
Return on equity (ROE) is 27.27% and return on invested capital (ROIC) is 61.88%.
| Return on Equity (ROE) | 27.27% |
| Return on Assets (ROA) | 14.04% |
| Return on Invested Capital (ROIC) | 61.88% |
| Return on Capital Employed (ROCE) | 26.41% |
| Weighted Average Cost of Capital (WACC) | 4.76% |
| Revenue Per Employee | $337,969 |
| Profits Per Employee | $67,841 |
| Employee Count | 226 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 1.67 |
Taxes
In the past 12 months, PLX has paid $3.93 million in taxes.
| Income Tax | 3.93M |
| Effective Tax Rate | 20.42% |
Stock Price Statistics
The stock price has increased by +24.05% in the last 52 weeks. The beta is 0.01, so PLX's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | +24.05% |
| 50-Day Moving Average | 2.11 |
| 200-Day Moving Average | 2.16 |
| Relative Strength Index (RSI) | 41.42 |
| Average Volume (20 Days) | 818,112 |
Short Selling Information
The latest short interest is 4.18 million, so 5.19% of the outstanding shares have been sold short.
| Short Interest | 4.18M |
| Short Previous Month | 4.73M |
| Short % of Shares Out | 5.19% |
| Short % of Float | 5.75% |
| Short Ratio (days to cover) | 5.29 |
Income Statement
In the last 12 months, PLX had revenue of $76.38 million and earned $15.33 million in profits. Earnings per share was $0.19.
| Revenue | 76.38M |
| Gross Profit | 34.55M |
| Operating Income | 19.79M |
| Pretax Income | 19.27M |
| Net Income | 15.33M |
| EBITDA | 21.31M |
| EBIT | 19.79M |
| Earnings Per Share (EPS) | $0.19 |
Balance Sheet
The company has $51.08 million in cash and $8.48 million in debt, with a net cash position of $42.60 million or $0.53 per share.
| Cash & Cash Equivalents | 51.08M |
| Total Debt | 8.48M |
| Net Cash | 42.60M |
| Net Cash Per Share | $0.53 |
| Equity (Book Value) | 67.23M |
| Book Value Per Share | 0.83 |
| Working Capital | 58.97M |
Cash Flow
In the last 12 months, operating cash flow was $15.09 million and capital expenditures -$2.09 million, giving a free cash flow of $13.00 million.
| Operating Cash Flow | 15.09M |
| Capital Expenditures | -2.09M |
| Depreciation & Amortization | 1.52M |
| Net Borrowing | n/a |
| Free Cash Flow | 13.00M |
| FCF Per Share | $0.16 |
Margins
Gross margin is 45.24%, with operating and profit margins of 25.91% and 20.07%.
| Gross Margin | 45.24% |
| Operating Margin | 25.91% |
| Pretax Margin | 25.22% |
| Profit Margin | 20.07% |
| EBITDA Margin | 27.90% |
| EBIT Margin | 25.91% |
| FCF Margin | 17.02% |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.19% |
| Shareholder Yield | 2.19% |
| Earnings Yield | 9.71% |
| FCF Yield | 8.23% |
Analyst Forecast
The average price target for PLX is $11.00, which is 461.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 461.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | 8.55% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PLX has an Altman Z-Score of -0.15 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.15 |
| Piotroski F-Score | 6 |